News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
798,562 Results
Type
Article (75783)
Company Profile (503)
Press Release (722255)
Multimedia
Podcasts (193)
Webinars (26)
Section
Business (206510)
Career Advice (3633)
Deals (37371)
Drug Delivery (149)
Drug Development (87798)
Employer Resources (188)
FDA (17332)
Job Trends (16228)
News (359651)
Policy (35583)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3013)
Academic (2)
Accelerated approval (40)
Adcomms (36)
Allergies (163)
Alliances (51557)
ALS (190)
Alzheimer's disease (1820)
Antibody-drug conjugate (ADC) (371)
Approvals (17548)
Artificial intelligence (627)
Autoimmune disease (191)
Automation (47)
Bankruptcy (362)
Best Places to Work (12434)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (341)
Bladder cancer (174)
Brain cancer (69)
Breast cancer (691)
Cancer (5280)
Cardiovascular disease (467)
Career advice (3111)
Career pathing (43)
CAR-T (318)
CDC (65)
Celiac Disease (2)
Cell therapy (866)
Cervical cancer (39)
Clinical research (74413)
Collaboration (1928)
Company closure (5)
Compensation (1207)
Complete response letters (79)
COVID-19 (2962)
CRISPR (107)
C-suite (962)
Cystic fibrosis (156)
Data (6655)
Decentralized trials (2)
Denatured (67)
Depression (158)
Diabetes (543)
Diagnostics (7156)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (302)
Drug pricing (226)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (83223)
Editorial (69)
Employer branding (23)
Employer resources (165)
Events (133038)
Executive appointments (1067)
FDA (20677)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1622)
Gene editing (230)
Generative AI (60)
Gene therapy (713)
GLP-1 (1141)
Government (5356)
Grass and pollen (8)
Guidances (387)
Healthcare (20610)
HIV (75)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (306)
Immuno-oncology (74)
Indications (131)
Infectious disease (3272)
Inflammatory bowel disease (217)
Inflation Reduction Act (17)
Influenza (130)
Intellectual property (266)
Interviews (697)
IPO (17524)
IRA (60)
Job creations (4166)
Job search strategy (2518)
JPM (73)
Kidney cancer (19)
Labor market (88)
Layoffs (649)
Leadership (44)
Legal (8526)
Liver cancer (97)
Longevity (18)
Lung cancer (714)
Lymphoma (394)
Machine learning (47)
Management (63)
Manufacturing (890)
MASH (180)
Medical device (14745)
Medtech (14810)
Mergers & acquisitions (20999)
Metabolic disorders (1451)
mRNA (197)
Multiple sclerosis (177)
NASH (22)
Neurodegenerative disease (382)
Neuropsychiatric disorders (107)
Neuroscience (3227)
Neurotech (1)
NextGen: Class of 2026 (7437)
Non-profit (4991)
Now hiring (63)
Obesity (706)
Opinion (344)
Ovarian cancer (175)
Pain (226)
Pancreatic cancer (248)
Parkinson's disease (314)
Partnered (36)
Patents (542)
Patient recruitment (547)
Peanut (65)
People (64441)
Pharmaceutical (91)
Pharmacy benefit managers (33)
Phase 1 (23199)
Phase 2 (32507)
Phase 3 (24303)
Pipeline (6015)
Policy (353)
Postmarket research (3058)
Preclinical (10294)
Press Release (71)
Prostate cancer (271)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (1006)
Real estate (6677)
Recruiting (78)
Regulatory (26649)
Reports (51)
Research institute (2702)
Resumes & cover letters (573)
Rett syndrome (30)
RNA editing (21)
RSV (89)
Schizophrenia (165)
Series A (274)
Series B (206)
Service/supplier (15)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (3923)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (96)
The Weekly (124)
Vaccines (1154)
Venture capital (101)
Weight loss (480)
Women's health (101)
Worklife (23)
Date
Today (185)
Last 7 days (942)
Last 30 days (3014)
Last 365 days (32139)
2026 (5405)
2025 (32374)
2024 (37323)
2023 (42061)
2022 (53373)
2021 (58234)
2020 (57042)
2019 (50690)
2018 (38460)
2017 (35507)
2016 (35852)
2015 (41735)
2014 (35356)
2013 (31357)
2012 (33270)
2011 (33398)
2010 (32256)
Location
Africa (1093)
Alabama (94)
Alaska (7)
Arizona (303)
Arkansas (15)
Asia (46428)
Australia (8236)
California (12044)
Canada (3433)
China (1220)
Colorado (500)
Connecticut (513)
Delaware (346)
Europe (108114)
Florida (1795)
Georgia (385)
Hawaii (3)
Idaho (66)
Illinois (994)
India (77)
Indiana (554)
Iowa (24)
Japan (462)
Kansas (133)
Kentucky (45)
Louisiana (29)
Maine (84)
Maryland (1489)
Massachusetts (8809)
Michigan (365)
Minnesota (670)
Mississippi (7)
Missouri (141)
Montana (35)
Nebraska (29)
Nevada (129)
New Hampshire (83)
New Jersey (3241)
New Mexico (33)
New York (3173)
North Carolina (1629)
North Dakota (10)
Northern California (5841)
Ohio (369)
Oklahoma (23)
Oregon (44)
Pennsylvania (2383)
Puerto Rico (25)
Rhode Island (49)
South America (1466)
South Carolina (69)
South Dakota (1)
Southern California (4697)
Tennessee (182)
Texas (1878)
United States (43099)
Utah (366)
Vermont (1)
Virginia (292)
Washington D.C. (83)
Washington State (990)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
798,562 Results for "the university of texas at san antonio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Atossa Therapeutics Presents Four Clinical Trial Updates Highlighting (Z)-Endoxifen Research at the 2025 San Antonio Breast Cancer Symposium
December 16, 2025
·
7 min read
Press Releases
Agendia to Showcase MammaPrint and BluePrint Utility in Guiding Anthracycline Therapy at the 2025 San Antonio Breast Cancer Symposium
November 26, 2025
·
5 min read
Press Releases
Plus Therapeutics to Present ReSPECT Phase 1 Dose Escalation Study Results for Leptomeningeal Metastases at the 2025 San Antonio Breast Cancer Symposium
December 2, 2025
·
6 min read
Press Releases
Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
December 4, 2025
·
9 min read
Press Releases
Atossa Therapeutics Announces Acceptance of Four Abstracts Highlighting (Z)-Endoxifen Research for Presentation at the 2025 San Antonio Breast Cancer Symposium
November 7, 2025
·
2 min read
Press Releases
Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium
December 3, 2025
·
4 min read
Press Releases
Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San Antonio Breast Cancer Symposium
December 3, 2025
·
5 min read
Job Trends
10 Companies Hiring in San Francisco and South San Francisco
Looking for a biopharma job in San Francisco or South San Francisco? Check out the
BioSpace
list of 10 companies hiring life sciences professionals like you.
February 26, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
December 10, 2025
·
7 min read
Press Releases
BBOT Announces Poster Presentations at the San Antonio Breast Cancer Symposium (SABCS)
October 31, 2025
·
2 min read
1 of 79,857
Next
